Stay updated on Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded a site-wide notice about government funding and status updates with links to cc.nih.gov and opm.gov, and updated the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check9 days agoChange DetectedThe Record History page now includes a glossary toggle, color-coded change highlights (green for additions, red for deletions), and explicit revision notes (e.g., Revision: v3.4.0) to aid understanding of history changes.SummaryDifference0.5%

- Check16 days agoChange DetectedAdded Revision: v3.3.4 to the history list. Removed Revision: v3.3.3 from the history list.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Revision: v3.3.3 to the Record History; removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision: v3.3.2 is now shown in the page history, replacing v3.3.1. This update does not alter any study records or displayed information on the page.SummaryDifference0.1%

- Check73 days agoChange DetectedRevision: v3.3.1 was added to the page's history, and Revision: v3.2.0 was removed. The changes pertain to the page’s revision log rather than study information.SummaryDifference0.1%

Stay in the know with updates to Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipatasertib Combo in Metastatic Prostate Cancer Clinical Trial page.